In this Review, the authors describe how dysregulated protein translation in cancer cells is an important source of tumour-specific peptides for immunosurveillance and how MHC class I antigen-processing and presentation pathways are manipulated by tumours for immunoevasion — information that will inform cancer immunotherapy approaches.
- Devin Dersh
- Jaroslav Hollý
- Jonathan W. Yewdell
